Precision Medicine Plan 'Golden Opportunity' For Device, Diagnostic Firms
This article was originally published in The Gray Sheet
A new proposed framework to realize President Obama's Precision Medicine Initiative has significant potential for device and diagnostic companies, according to NIH Director Francis Collins. He says it will give them a "competitive opportunity" to develop cheaper whole genome sequencing tests and open the door to other exciting technologies.
Register for our free email digests: